Last updated on March 2019

A Study to Evaluate the Pharmacokinetics Safety and Tolerability of Intravenous Brivaracetam in Subjects >= 1 Month to < 16 Years of Age With Epilepsy

Brief description of study

The purpose of the study is to evaluate the pharmacokinetics (PK), safety, and tolerability of brivaracetam (BRV) administered intravenously (iv) in subjects >= 1 month to < 16 years of age with epilepsy.

Clinical Study Identifier: NCT03405714

Find a site near you

Start Over

Ep0065 232

Miskolc, Hungary
  Connect »